Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Net Income: 2019-2025

Historic Net Income for Benitec Biopharma (BNTC) over the last 7 years, with Jun 2025 value amounting to -$38.5 million.

  • Benitec Biopharma's Net Income fell 90.10% to -$8.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$38.5 million, marking a year-over-year decrease of 78.26%. This contributed to the annual value of -$38.5 million for FY2025, which is 78.26% down from last year.
  • As of FY2025, Benitec Biopharma's Net Income stood at -$38.5 million, which was down 78.26% from -$21.6 million recorded in FY2024.
  • Benitec Biopharma's 5-year Net Income high stood at -$13.6 million for FY2021, and its period low was -$38.5 million during FY2025.
  • Over the past 3 years, Benitec Biopharma's median Net Income value was -$21.6 million (recorded in 2024), while the average stood at -$26.4 million.
  • Data for Benitec Biopharma's Net Income shows a maximum YoY slumped of 78.26% (in 2025) over the last 5 years.
  • Benitec Biopharma's Net Income (Yearly) stood at -$13.6 million in 2021, then plummeted by 31.50% to -$17.9 million in 2022, then declined by 6.87% to -$19.1 million in 2023, then decreased by 12.93% to -$21.6 million in 2024, then tumbled by 78.26% to -$38.5 million in 2025.